References
Bate CM, Richardson PDI. PharmacoEconomics 3: 94–99, 1993
Crean G. Prescriber January: 29–37, 1992
Bate CM, et al. Br J Clin Res 2: 133–148, 1991
McCallum RW, et al. Drugs 36: 652–681, 1988
Holt S, Howden CW. Digest Dis Sci 36: 385–393, 1991
Bate CM. Br J Med Econ 1: 53–61, 1991
Bate CM, Richardson PDI. Br J Med Econ 2: 37–48, 1992
Bate CM, Richardson PDI. Br J Med Econ 2: 5–11, 1992
Hillman AL, et al. Arch Intern Med 152: 1467–1472, 1992
Hatlebakk JG, et al. Scand J Gastroenterol 28: 224–228, 1993
Goldberg J. Am J Gastroenterol 86: 1585–1587, 1991
Sekiguchi T, et al. Gastroenterol Jap 26: 137–144, 1991
Ducrotté P. Gastroentewlogy 102: A62, 1992
Mundo M, et al. Am J Gastroenterol 87: 1254, 1992
Beretta L, et al. Curr Ther Res 49: 968–972, 1991
Galmiche JP, et al. Dig Dis Sci 35: 649–655, 1990
Toussaint J J Drug Dev 5 (Suppl. 2): 15–19, 1993
Blum AL, et al. Dig Dis Sci 38: 551–560, 1993
Tytgat GNJ, et al. Scand J Gastroenterol 27: 175–183, 1992
Anon. Inpharma 873: 22, 1993
Rights and permissions
About this article
Cite this article
Cost Effectiveness of GORD Therapy. Drugs Ther. Perspect 2, 14–16 (1993). https://doi.org/10.2165/00042310-199302010-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199302010-00007